Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Not yet recruiting × Cardiotoxicity × Clear all

Phase

Phase NA 4 Phase 4 1 Phase 1/2 1

Status

Unknown 2 Recruiting 2 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 16 Multiple Myeloma 6 Stomach Neoplasms 5 Colorectal Neoplasms 5 Carcinoma, Hepatocellular 4 Uterine Cervical Neoplasms 3 Ovarian Neoplasms 3 Melanoma 3 Lung Neoplasms 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Endometrial Neoplasms 3 Waldenstrom Macroglobulinemia 2 Venous Thromboembolism 2 Urinary Bladder Neoplasms 2 Thyroid Nodule 2 Stomatitis 2 Small Cell Lung Carcinoma 2 Skin Neoplasms 2 Prostatic Neoplasms 2 Pancreatic Cancer Non-resectable 2 Neoplasms 2 Neoplasm Metastasis 2 Myasthenia Gravis 2 Lymphoma, B-Cell 2 Lymphoma 2 Gastric / Gastroesophageal Junction Adenocarcinoma 2 Febrile Neutropenia 2 Carcinoma, Non-Small-Cell Lung 2 Anemia 2 Acute Kidney Injury 2

Interventions

Rosuvastatin Calcium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07254221 2025-12-10

ROSUBREAST

Shiraz University of Medical Sciences

Phase 4 Not yet recruiting

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡